Skip to main content
    C

    Candel Therapeutics Inc (CADL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.81
    -0.39 (-6.29%)

    Market Cap: $486.37M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Candel Therapeutics Inc (CADL) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Candel Therapeutics (CADL) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Candel Therapeutics reported EPS of -$0.28, above the -$0.30 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    48%(10/21)
    Avg Surprise
    -6.20%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.38
    Range-$0.60 - -$0.08
    12 analysts
    Revenue Consensus
    N/A
    RangeN/A
    11 analysts
    Reports May 12, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.32
    Range-$0.32 - -$0.32
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago-$0.320.0%
    7d ago-$0.320.0%
    Current-$0.32
    Revenue Consensus
    N/A
    RangeN/A
    2 analysts

    Next Report

    CADL has an expected report date of Mar 10, 2027.

    Earnings History

    Of the 21 quarters below that had an estimate, CADL beat 10 and missed 11. The widest gap in the table came in the quarter ended Dec 31, 2021, when EPS landed 196.88% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.28-$0.30-$0.33 - -$0.29+6.67%BeatN/A20 up, 1 downNov 12, 2026N/A
    Jun 30, 2026-$0.35-$0.22-$0.26 - -$0.21-59.09%MissN/A20 up, 0 downAug 13, 2026N/A
    Mar 31, 2026-$0.14-$0.33-$0.52 - -$0.24+57.58%BeatN/A50 up, 3 downMay 14, 2026N/A
    Dec 31, 2025-$0.29-$0.25-$0.25 - -$0.22-17.01%MissN/A22 up, 0 downMar 12, 2026N/A
    Sep 30, 2025-$0.23-$0.16-$0.21 - -$0.12-43.75%MissN/A21 up, 0 downNov 13, 2025N/A
    Jun 30, 2025-$0.20-$0.17-$0.18 - -$0.17-17.65%MissN/A21 up, 0 downAug 14, 2025N/A
    Mar 31, 2025-$0.14-$0.24-$0.24 - -$0.24+41.67%BeatN/A11 up, 0 downMay 13, 2025N/A
    Dec 31, 2024-$0.40-$0.30N/A-33.33%MissN/AN/AN/AMar 13, 2025$1.00M
    Sep 30, 2024-$0.33N/AN/AN/AN/AN/AN/AN/ANov 14, 2024N/A
    Jun 30, 2024-$0.74N/AN/AN/AN/AN/AN/A0 up, 0 downAug 13, 2024N/A
    Mar 31, 2024-$0.28-$0.28N/A-0.57%MissN/AN/A0 up, 0 downMay 14, 2024N/A
    Dec 31, 2023-$0.38-$0.16-$0.16 - -$0.16-137.50%MissN/A10 up, 0 downMar 28, 2024$1.78M
    Sep 30, 2023-$0.29-$0.19-$0.19 - -$0.19-52.63%MissN/A10 up, 0 downNov 9, 2023N/A
    Jun 30, 2023-$0.33-$0.37-$0.37 - -$0.23+10.81%BeatN/A20 up, 0 downAug 10, 2023N/A
    Mar 31, 2023-$0.30-$0.35N/A+14.29%BeatN/A21 up, 0 downMay 11, 2023N/A
    Dec 31, 2022-$0.18-$0.31-$0.54 - -$0.16+41.94%Beat-158.1%30 up, 0 downMar 30, 2023$32000
    Sep 30, 2022-$0.31-$0.36-$0.53 - -$0.19+13.89%BeatN/A30 up, 0 downNov 10, 2022$31000
    Jun 30, 2022-$0.32-$0.43N/A+25.58%BeatN/A20 up, 0 downAug 5, 2022$31000
    Mar 31, 2022-$0.32-$0.31-$0.42 - -$0.21-3.23%MissN/A30 up, 0 downMay 12, 2022$31000
    Dec 31, 2021$0.31-$0.32-$0.49 - -$0.20+196.88%BeatN/A30 up, 0 downMar 29, 2022$32000
    Sep 30, 2021-$0.34-$0.29-$0.31 - -$0.27-17.24%MissN/A2N/ANov 12, 2021$31000
    Jun 30, 2021-$0.31-$0.12-$0.12 - -$0.12-158.33%MissN/A1N/AJul 28, 2021$31000
    Mar 31, 2021-$0.35-$0.35N/A+0.74%BeatN/AN/AN/AJun 2, 2021$31000
    Last 23 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.86, after -$1.75 the year before. It was -$0.69 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.86N/A
    Dec 31, 2024-$1.75N/A
    Dec 31, 2023-$1.30N/A
    Dec 31, 2022-$1.13N/A
    Dec 31, 2021-$0.69N/A

    Frequently Asked Questions About CADL

    When is Candel Therapeutics's next earnings date?

    Candel Therapeutics's next earnings report is expected for Mar 10, 2027.

    Did CADL beat earnings estimates last quarter?

    Yes. Candel Therapeutics reported EPS of -$0.28 for the quarter ended Sep 30, 2026, above the -$0.30 estimate, a 6.67% surprise.

    What EPS do analysts expect from CADL next quarter?

    The consensus EPS estimate for Candel Therapeutics for the quarter ending Dec 31, 2026 is -$0.38 from 12 analysts, with estimates from -$0.60 to -$0.08.

    How often does CADL beat earnings estimates?

    Candel Therapeutics beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -8.12%.